Myelodysplastic Syndrome

MD IQ

Conference Coverage

'Paradigm shift’: Luspatercept for MDS

In a first head-to-head comparison study, luspatercept for MDS significantly outperformed epoetin alfa in reducing transfusion dependence.

Pages